Safety Study of VH4770359 in Healthy Adults
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 55 years old
- Body mass index (BMI) between 18.5 and 37.0 (a measure of body size relative to height)
- Women must not be pregnant or breastfeeding, and must not be able to become pregnant; men must agree to use contraception or abstain from sex
- No serious liver, heart, stomach, lung, kidney, blood, or nervous system conditions
- No hepatitis B, hepatitis C, or HIV infection
- No regular use of alcohol, recreational drugs, or nicotine products (including vaping)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study tests a new oral drug to see if it is safe and how the body processes it. It is for healthy adults without HIV, and results will help determine if the drug could be used for HIV prevention in the future.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This early-stage study tests a new HIV medication (VH4524184) to understand how your body absorbs and processes it. You'll take a single dose of the medication with a small amount of radioactive tracer, which helps researchers track where the drug goes in your body.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.